FdaApplication
ANDA 214395
Identifiers
- fda_app_no: ANDA214395
Properties
| Property | Value |
|---|---|
| applicant_name | GUANGZHOU NOVAKEN PHARM CO LTD |
| application_type | ANDA |
| approval_date | 2021-01-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE;ORAL |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 20MEQ | TABLET, EXTENDED RELEASE;ORAL |
2 products